These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 1268089)

  • 1. A standardized bioassay for platelet factor 3 released by kaolin.
    Pérez-Requejo JL
    Br J Haematol; 1976 May; 33(1):39-51. PubMed ID: 1268089
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lack of platelet factor-3 activation after incubation of platelet-rich plasma with kaolin in the rat.
    Clerck FD; Goossens J; Beerens M
    Experientia; 1976 Dec; 32(12):1602-3. PubMed ID: 1021463
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evidence that von Willebrand factor is not required for the clotting of plasma in the presence of platelets and kaolin (Hardisty-Hutton test).
    McPherson J; Soberano ME; Macdonald C; Zucker MB
    Thromb Haemost; 1984 Apr; 51(2):272-4. PubMed ID: 6429885
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Determination of platelet factor 3 by thrombin generation using a micro-coagulation assay.
    Kirchhof B; Balleisen L
    Thromb Res; 1982 Aug; 27(3):303-10. PubMed ID: 6890246
    [TBL] [Abstract][Full Text] [Related]  

  • 5. THE KAOLIN CLOTTING TIME OF PLATELET-RICH PLASMA: A TEST OF PLATELET FACTOR-3 AVAILABILITY.
    HARDISTY RM; HUTTON RA
    Br J Haematol; 1965 May; 11():258-68. PubMed ID: 14282063
    [No Abstract]   [Full Text] [Related]  

  • 6. Analysis of platelet factor 3 in platelet concentrates stored for transfusion.
    Bode AP; Miller DT
    Vox Sang; 1986; 51(4):299-305. PubMed ID: 3798864
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Platelet activity ratio. A new approach for quantitation of platelet factor 3.
    Saleem A; Kreig AF; Cieslica R
    Am J Clin Pathol; 1975 Jan; 63(1):68-73. PubMed ID: 1111276
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association of factor V activity with membranous vesicles released from human platelets: requirement for platelet stimulation.
    Bode AP; Sandberg H; Dombrose FA; Lentz BR
    Thromb Res; 1985 Jul; 39(1):49-61. PubMed ID: 3839943
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Platelet antibody determination by platelet factor 3 assay (comparison with radiolabelled serotonin release and platelet aggregometry).
    Leone G; Breda M; Accorrà F; Bizzi B
    Ric Clin Lab; 1978; 8(3):141-7. PubMed ID: 746295
    [TBL] [Abstract][Full Text] [Related]  

  • 10. STUDIES ON PLATELET FACTOR-3 AVAILABILITY.
    SPAET TH; CINTRON J
    Br J Haematol; 1965 May; 11():269-75. PubMed ID: 14282064
    [No Abstract]   [Full Text] [Related]  

  • 11. [Studies of platelet factor-3 by the kaolin clotting time and thromboplastin generation time].
    Oki H; Takashima A
    Rinsho Byori; 1973 Jul; 21(7):621-6. PubMed ID: 4738067
    [No Abstract]   [Full Text] [Related]  

  • 12. Procoagulant activity of platelets.
    Kardinal CG; Wegener LT; Anderson LK; Wallin JD
    Arch Pathol; 1975 Aug; 99(8):449-51. PubMed ID: 1147840
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Familial bleeding tendency associated with microcytic platelets and impaired release of platelet adenosine diphosphate.
    Maurer HM; Still WJ; Caul J; Valdes OS; Laupus WE
    J Pediatr; 1971 Jan; 78(1):86-94. PubMed ID: 5539087
    [No Abstract]   [Full Text] [Related]  

  • 14. PARTIAL THROMBOPLASTIN TIME TEST WITH KAOLIN. NORMAL RANGE AND MODIFICATIONS FOR THE DIAGNOSIS OF HAEMOPHILIA AND CHRISTMAS DISEASE.
    MATCHETT MO; INGRAM GI
    J Clin Pathol; 1965 Jul; 18(4):465-71. PubMed ID: 14318702
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The kaolin partial thromboplastin time as a screening test for coagulation disorders.
    Lurie A; Smith S
    S Afr Med J; 1968 May; 42(18):438-44. PubMed ID: 5655371
    [No Abstract]   [Full Text] [Related]  

  • 16. Anticoagulant Activities of Indobufen, an Antiplatelet Drug.
    Liu J; Xu D; Xia N; Hou K; Chen S; Wang Y; Li Y
    Molecules; 2018 Jun; 23(6):. PubMed ID: 29914049
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Potassium, magnesium, copper, manganese and cobalt salts of aspartic acid on platelet factor 3 availability (author's transl)].
    Reuter HD; Schröter G
    Arzneimittelforschung; 1980; 30(12):2106-8. PubMed ID: 7194069
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hemostatic defect due to acquired circulating inhibitors against lipid procoagulant and factor VIII.
    Pechet L; Snyder LM; Chesney C; Colman RW
    Thromb Diath Haemorrh; 1974 Sep; 32(1):90-104. PubMed ID: 4548947
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Platelet factor 3 assay and the availability of platelet factor 3 in collagen or thrombin stimulated platelets.
    Brox JH; Osterud B
    Thromb Res; 1984 Mar; 33(5):555. PubMed ID: 6719401
    [No Abstract]   [Full Text] [Related]  

  • 20. [The determination of platelet factor 3 using hirudin].
    Wamhoff D
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1975; 102(1):82-7. PubMed ID: 50972
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.